← Eichor
Study identifier: NCT06699979 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

Condition: Lung Cancer Associated With Cystic Airspaces · Multiple Primary Lung Cancers · Non-Small Cell Lung Cancer  ·  Sponsor: Central South University

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to investigate the multi-omics characterization early-stage lung cancer exhibiting distinct phenotypes including lung cancer associated with cystic airspaces, multiple primary lung cancers, and so on. The main questions it aims to answer are: * What are the differences in pathogenesis of non-small cell lung cancer with different phenotypes explored by multi-omics? * Whether differential genes lead to potential prognostic models and therapeutic targets? Participants will be followed up after surgery to answer prognosis: whether they have recurred, and the time to recurrence.

This description comes directly from the study's public registry record.

Talk to the study team

Chen Chen  ·  +8673185295188  ·  chenchen1981412@csu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The Second Xiangya Hospital of Central South UniversityChangsha, Hunan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06699979